Depression and panic disorder after heart transplantation - Treatment with sertraline

Pharmacopsychiatry

Volumn 35, Issue 1, 2002, Pages 31-32

  Hesslinger, Bernd ^a   Van de Loo, A ^a   Klecha, D ^a   Harter M ^a   Schmidt Schweda, S ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CALCIUM; CYCLOSPORIN A; DILTIAZEM; HYDROCHLOROTHIAZIDE; LORAZEPAM; OMEPRAZOLE; PREDNISOLONE; SERTRALINE; SIMVASTATIN; VALSARTAN;

ADULT; CARDIOTOXICITY; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HEART TRANSPLANTATION; HUMAN; MALE; PANIC; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SHORT SURVEY; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PANIC DISORDER; SERTRALINE;

EID: 0036173486     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-19835     Document Type: Short Survey

References (8)

1. Prevalence and predictors of depression and anxiety-related disorders during the year after heart transplantation
2. The use of antidepressant drugs in patients with heart disease
3. Depression in patients being evaluated for heart transplantation
4. The relationship of depression to cardiovascular disease. Epidemiology, biology, and treatment
5. Fatal overdose with citalopram
6. Sertraline in the treatment of panic disorder. A flexible-dose multicenter trial
7. Potassium, antipsychotic agents, arrythmias and sudden death
8. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial)